Current Edition


Sprout hopes women will think pink when it comes to treating Hypoactive Sexual Desire Disorder

Pfizer’s Viagra is so much a part of the cultural landscape that, “little blue pill” is often all that’s needed to identify the drug. Not …

Continue Reading →

Roche’s aim to widen Evrysdi’s label nabs speedy FDA review in young spinal muscular atrophy patients

Now poised for a speedy trip through the FDA’s regulatory review, Roche’s oral challenger in spinal muscular atrophy (SMA) could soon pick up a nod …

Continue Reading →